首次出版:最新修訂:March 2009交付方式:特快專遞(2-3天送達(dá))
報(bào)告屬性:共77頁下載目錄 版權(quán)聲明
定購電話:0755-82571522、82571566、400-008-1522
24小時(shí)服務(wù)熱線:138 0270 8576 定制報(bào)告
版本 | 在線版 | 電子版+印刷版 | 在線報(bào)告庫(超1000份報(bào)告)全庫 |
---|---|---|---|
優(yōu)惠價(jià) | RMB 6800 | RMB 7800 | RMB 9800 |
原價(jià) | RMB 9600 | RMB 9800 | - |
聯(lián)系電話: 400 008 0586; 0755-82571568
微信掃碼:
1.EXECUTIVESUMMARY
ExecutiveSummary
·Introduction
2.MARKETINTRODUCTION
Introduction
·MultipleSclerosis
·ScopeandSegmentation
·ResearchMethodology
DiseaseOverview
·CausesofMultipleSclerosis
·ClassificationofMultipleSclerosis
·TreatmentOptions
MarketOverview
·MarketEngineeringMeasurements
·MarketTrends
3.MARKETANALYSIS
ProductAnalysis
·Interferons
·Copaxone
·Tysabri
·Novantrone
·PipelineDrugs
PatientForecasts
·TotalPatientForecasts
·PatientForecastbyProduct
RevenueForecasts
·TotalMarketRevenueForecasts
·RevenueForecastsbyProduct
CompetitiveAnalysis
·CompetitiveStructure
·CompanyMarketShare
CompetitveMetrics
·MethodologyandMetrics
·BiogenIdec
·TevaPharmaceuticals
·EMDSerono
·BayerScheringPharma
·EmergingCompanies
4.DECISIONSUPPORTDATABASES
DemographicIndicators
·TotalPopulation
MarketIndicators
·WorldMultipleSclerosisPrevalence
·U.S.MultipleSclerosisPrevalence
·U.S.MultipleSclerosisIncidence
·PharmaceuticalR&DExpenditure
This research service provides revenue forecasts, market shares, projected prevalence and treated populations, market trends, and existing and emerging therapeutics. There is a competitive and product analysis of the major market participants and products with competitive metrics for major and emerging companies.